维普中文期刊产品整合服务
11篇 您的检索式:作者名="Andrew Tai"
    题名 作者 年代 出处 被引量
1Hepatitis B Virus Core Promoter Mutations Contribute to Hepatocarcinogenesis by Deregulating SKP2 and Its Target, p21显示文摘Yuehua Huang Shuping Tong Andrew W. Tai Munira Hussain Anna S.F. Lok 2011Gastroenterology2011,,4:2
2Hepatitis B Virus Core Promoter Mutations Contribute to Hepatocarcinogenesis by Deregulating SKP2 and Its Target, p21显示文摘Yuehua Huang Shuping Tong Andrew W. Tai Munira Hussain Anna S.F. Lok 2011Gastroenterology2011,,4:1
3A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication显示文摘Andrew W. Tai Yair Benita Lee F. Peng Sun-Suk Kim Naoya Sakamoto Ramnik J. Xavier Raymond T. Chung 2009Cell Host & Microbe2009,,3:1
4Vasoactive Mediators and Pulmonary Hypertension After Cigarette Smoke Exposure in the Guinea Pig显示文摘Wright JL Hsin Tai Andrew Churg 2006J Appl Physiol2006,100,10:1
5Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection显示文摘Kyung-Ah Kim Wenyu Lin Andrew W. Tai Run-Xuan Shao Ethan Weinberg Carolina B. De Sa Borges Atul K. Bhan Hui Zheng Yoshitaka Kamegaya Raymond T. Chung 2009Journal of Hepatology2009,,4:1
6Cigarette Smoke Drives Small Airway Remodeling by Induction of Growth Factors in the Airway Wall 显示文摘Andrew Churg Hsin Tai Tonya Coulthard 2006Am J Respir Crit Care Med2006,,12:1
7Tumor necrosis factorαdrives 70% of cigarette,smoke-induced emphysema in the mouse显示文摘Andrew Churg Rong D Wang Hsin Tai 2004American Journal of Respiratory and Critical Care Medicine2004,170,:1
8A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication显示文摘Andrew W. Tai Yair Benita Lee F. Peng Sun-Suk Kim Naoya Sakamoto Ramnik J. Xavier Raymond T. Chung 2009Cell Host & Microbe2009,,3:1
9Tumor necrosis factor-α drives 70% of cigarette smoke-induced emphysema in the mouse显示文摘Andrew Churg Rong D Wang Hsin Tai 2004American Journal of Respiratory and Critical Care Medicine2004,,170:1
10Systematic evaluation of three porcine-derived collagen membranes for guided bone regeneration显示文摘Guided bone regeneration is one of the most common surgical treatment modalities performed when an additional alveolar bone is required to stabilize dental implants in partially and fully edentulous patients.The addition of a barrier membrane prevents non-osteogenic tissue invasion into the bone cavity,which is key to the success of guided bone regeneration.Barrier membranes can be broadly classified as non-resorbable or resorbable.In contrast to non-resorbable membranes,resorbable barrier membranes do not require a second surgical procedure for membrane removal.Commercially available resorbable barrier membranes are either synthetically manufactured or derived from xenogeneic collagen.Although collagen barrier membranes have become increasingly popular amongst clinicians,largely due to their superior handling qualities compared to other commercially available barrier membranes,there have been no studies to date that have compared commercially available porcine-derived collagen membranes with respect to surface topography,collagen fibril structure,physical barrier property,and immunogenic composition.This study evaluated three commercially available non-crosslinked porcine-derived collagen membranes(Striate+TM,Bio-Gide®and CreosTM Xenoprotect).Scanning electron microscopy revealed similar collagen fibril distribution on both the rough and smooth sides of the membranes as well as the similar diameters of collagen fibrils.However,D-periodicity of the fibrillar collagen is significantly different among the membranes,with Striate+TM membrane having the closest D-periodicity to native collagen I.This suggests that there is less deformation of collagen during manufacturing process.All collagen membranes showed superior barrier property evidenced by blocking 0.2–16.4µm beads passing through the membranes.To examine the immunogenic agents in these membranes,we examined the membranes for the presence of DNA and alpha-gal by immunohistochemistry.No alpha-gal or DNA was detected in any membranes.However,using a more sensitive detection method(real-time polymerase chain reaction),a relatively strong DNA signal was detected in Bio-Gide®membrane,but not Striate+TM and CreosTM Xenoprotect membranes.Our study concluded that these membranes are similar but not identical,probably due to the different ages and sources of porcine tissues,as well as different manufacturing processes.We recommend further studies to understand the clinical implications of these findings.Andrew Tai Euphemie Landao-Bassonga Ziming Chen Minh Tran Brent Allan Rui Ruan Dax Calder Mithran Goonewardene Hien Ngo Ming Hao Zheng 2023Biomaterials Translational2023,4,1:0
11Reporting guidelines of Chinese medicine:Current situation and future development显示文摘Objective:Reporting research is as important a part of a study as its design or analysis.Reporting guidelines(RGs)provide structured advice on how to report research studies clearly and adequately.This study aimed to review the development of RGs of Chinese medicine(CM)and to provide recommen-dations for improvement.Methods:Through a systematic search of the Enhancing the QUAlity and Transparency Of health Research(EQUATOR)Network and electronic databases up to January 1,2022,we identified a total of 15 RGs of CM,and further summarized their characteristics and applications.In addition,we reviewed the development of international RGs and analyzed its impact for CM.Results:Compared with the generic RGs,the reporting standards of CM have been rapidly developed over the last 10 years,of which 57%were issued in recent 3 years(2019-2021).Currently,the system of RGs of CM has been established,especially for clinical trials,including various CM interventions and covering the guidelines from trial registration,protocol,results publication to the evidence synthesis and clinical practice guideline.However,the application of RGs of CM is suboptimal.Conclusion:It is necessary to take further measures to promote practical application,improve journals’endorsement,and establish quality monitoring procedures for RGs of CM in the future.Xuan Zhang Wai Chak Andrew Chung Chung Tai Lau Nana Wang 2022Journal of Traditional Chinese Medical Sciences2022,9,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费